Revenue: €3,808 million in 2010 (+4.8% compared to 2009 at constant exchange rates)
Nearly 13,000 employees worldwide
More than 50% of staff devoted to industrial operations
12 production and/or R&D sites located in Marcy l'Etoile and Val de Reuil, France; in Swiftwater (Pennsylvania), Cambridge and Canton (Massachusetts), Orlando (Florida) and Rockville (Maryland), USA; in Toronto, Canada; in Pilar, Argentina; in Shenzhen, China; in Hyderabad, India and in Chachoengsao, Thailand.
3 new facilities under construction in Ocoyoacac, Mexico ; Neuville, France ; and Shenzhen, China.
Investment in research and production capacity:
More than 1 billion doses of vaccines produced yearly to immunize more than 500 million people in the world